Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,078 | 403 | 94.2% |
| Education | $455.85 | 6 | 5.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38.82 | 2 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $867.19 | 51 | $0 (2024) |
| Novo Nordisk Inc | $862.18 | 56 | $0 (2024) |
| Lilly USA, LLC | $753.17 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $712.76 | 27 | $0 (2022) |
| Astellas Pharma US Inc | $553.04 | 19 | $0 (2021) |
| Merck Sharp & Dohme LLC | $449.60 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $430.30 | 5 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $392.60 | 18 | $0 (2024) |
| PFIZER INC. | $358.64 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $343.66 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $446.07 | 22 | Lilly USA, LLC ($98.42) |
| 2023 | $985.85 | 44 | Novo Nordisk Inc ($174.05) |
| 2022 | $725.52 | 38 | Novo Nordisk Inc ($131.34) |
| 2021 | $1,389 | 77 | Lilly USA, LLC ($166.43) |
| 2020 | $839.42 | 51 | Lilly USA, LLC ($150.62) |
| 2019 | $1,176 | 57 | Astellas Pharma US Inc ($252.74) |
| 2018 | $1,550 | 57 | Novartis Pharmaceuticals Corporation ($269.19) |
| 2017 | $1,461 | 65 | Shire North American Group Inc ($233.71) |
All Payment Transactions
411 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: DIABETES | ||||||
| 11/13/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $32.30 | General |
| Category: VACCINE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: WOMENS HEALTH | ||||||
| 07/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: Diabetes | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: DIABETES | ||||||
| 05/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: DIABETES | ||||||
| 02/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: RESPIRATORY | ||||||
| 01/23/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: DIABETES | ||||||
| 12/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: RESPIRATORY | ||||||
| 11/22/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,692 | 3,907 | $346,065 | $157,650 |
| 2022 | 24 | 2,049 | 3,111 | $608,651 | $270,330 |
| 2021 | 24 | 2,359 | 3,317 | $679,417 | $359,198 |
| 2020 | 25 | 2,210 | 3,083 | $348,191 | $136,287 |
All Medicare Procedures & Services
94 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 288 | 646 | $116,340 | $40,276 | 34.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 213 | 339 | $74,610 | $32,692 | 43.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 14 | 1,200 | $31,200 | $19,647 | 63.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 175 | 184 | $19,260 | $13,116 | 68.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 43 | 44 | $19,800 | $12,394 | 62.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 87 | 87 | $17,450 | $11,693 | 67.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 330 | 762 | $15,240 | $6,384 | 41.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 166 | 175 | $6,125 | $5,688 | 92.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 36 | $11,700 | $5,010 | 42.8% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 14 | 16 | $4,000 | $2,743 | 68.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 36 | 36 | $7,200 | $2,214 | 30.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 43 | 44 | $1,540 | $1,430 | 92.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 68 | 68 | $6,800 | $1,329 | 19.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 24 | 32 | $4,160 | $1,193 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 73 | $3,360 | $773.50 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 41 | $3,075 | $477.75 | 15.5% |
| 90471 | Administration of vaccine | Office | 2023 | 24 | 25 | $875.00 | $359.10 | 41.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 25 | 35 | $700.00 | $119.35 | 17.1% |
| 82272 | Stool analysis for blood, by peroxidase activity | Office | 2023 | 11 | 11 | $220.00 | $45.65 | 20.8% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 19 | 19 | $1,900 | $34.65 | 1.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 34 | $510.00 | $31.84 | 6.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 281 | 662 | $119,160 | $43,772 | 36.7% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 83 | 83 | $83,000 | $40,956 | 49.3% |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | Office | 2022 | 103 | 103 | $77,250 | $39,190 | 50.7% |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | Office | 2022 | 69 | 69 | $69,000 | $34,052 | 49.4% |
About Dr. Robert Cooper, M.D
Dr. Robert Cooper, M.D is a Geriatric Medicine healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235159898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Cooper, M.D has received a total of $8,573 in payments from pharmaceutical and medical device companies, with $446.07 received in 2024. These payments were reported across 411 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,078).
As a Medicare-enrolled provider, Cooper has provided services to 8,310 Medicare beneficiaries, totaling 13,418 services with total Medicare billing of $923,465. Data is available for 4 years (2020–2023), covering 94 distinct procedure/service records.
Practice Information
- Specialty Geriatric Medicine
- Location Baltimore, MD
- Active Since 07/19/2006
- Last Updated 12/14/2009
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235159898
Products in Payments
- FARXIGA (Drug) $810.16
- ELIQUIS (Drug) $507.05
- JARDIANCE (Drug) $455.97
- Ozempic (Drug) $388.84
- ENTRESTO (Drug) $343.66
- TRULICITY (Drug) $321.08
- PRALUENT (Drug) $269.49
- Rybelsus (Drug) $217.29
- Vascepa (Drug) $205.53
- INVOKANA (Drug) $202.52
- JANUVIA (Drug) $187.28
- SOLIQUA (Drug) $171.69
- EMGALITY (Drug) $155.74
- TRELEGY ELLIPTA (Drug) $147.30
- ELAPRASE (Biological) $147.13
- CERDELGA (Drug) $145.05
- MYRBETRIQ (Drug) $142.94
- MOUNJARO (Drug) $129.55
- UBRELVY (Drug) $129.19
- CHANTIX (Drug) $125.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Geriatric Medicine Doctors in Baltimore
Dr. Gloria Damien, M.d, M.D
Geriatric Medicine — Payments: $8,109
Esther Oh, M.d, M.D
Geriatric Medicine — Payments: $5,300
Dr. James Richardson, M.d., M.p.h, M.D., M.P.H
Geriatric Medicine — Payments: $2,947
Dr. Amy Freedman, Md, MD
Geriatric Medicine — Payments: $2,348
Dima Hnoosh, M.d, M.D
Geriatric Medicine — Payments: $1,700
Charmian Sittambalam, Md, MD
Geriatric Medicine — Payments: $1,503